Clinical, Morphological and Morphometric Analysis of the Interatrial Septum in Patients with Coronary Heart Disease and Obesity

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

INTRODUCTION: Obesity is an important factor that facilitates the development of lipomatosis and fibrosis of the interatrial septum (IAS). Currently, non-invasive methods for assessing these pathological conditions are being actively developed. To introduce the developed methods in routine clinical practice, it is necessary to confirm the comparability of their results with the results of morphological studies.

AIM: To conduct clinical, morphological and morphometric analysis of the IAS in patients with coronary heart disease (CHD) and obesity.

MATERIALS AND METHODS: The study included 116 patients with the diagnosis of CHD, who underwent anthropometric measurements and echocardiography (EchoCG). Morphological and morphometric examinations were conducted on the material taken on autopsy from 74 patients with the main diagnosis of CHD. All patients were diagnosed with arterial hypertension.

RESULTS: Based on body mass index, patients with degree 1 obesity predominated. Based on EchoCG results, thickness of IAS in the group of patients with abdominal obesity was greater than in the group of patients without abdominal obesity. In morphometric examination, the percentage of adipose tissue in the IAS was higher in the group of patients with obesity than in the group without obesity.

CONCLUSIONS: The thickness of IAS is associated with increased parameters of waist circumference, body mass index and epicardial fat, based on the results of EchoCG. In the morphological examination, an increase in the thickness of epicardial fat and IAS was recorded in patients with obesity. Based on the morphometry data, the percentage of adipose tissue in histological samples of IAS was statistically higher in the group of patients with CHD and abdominal obesity than in patients without obesity (p=0.0002).

Full Text

Restricted Access

About the authors

Tatyana M. Cherdantseva

Ryazan State Medical University

Email: cherdan.morf@yandex.ru
ORCID iD: 0000-0002-7292-4996
SPIN-code: 3773-8785

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Ryazan

Aleksandra V. Solovyeva

Ryazan State Medical University

Email: savva2005@bk.ru
ORCID iD: 0000-0001-7896-6356
SPIN-code: 1943-7765

MD, Dr. Sci. (Medicine), Assistant Professor

Russian Federation, Ryazan

Iliya B. Glukhovets

Ryazan State Medical University

Email: gluchoveci@gmail.com
ORCID iD: 0000-0002-5158-9463
SPIN-code: 5261-5174

MD, Cand. Sci. (Medicine)

Russian Federation, Ryazan

Aleksey V. Cheskidov

Ryazan State Medical University

Email: a.v.cheskidov@yandex.ru
ORCID iD: 0000-0001-9468-0438
SPIN-code: 8421-5097

MD, Cand. Sci. (Medicine)

Russian Federation, Ryazan

Viktor V. Shelomentsev

Ryazan State Medical University

Author for correspondence.
Email: shelvit94@gmail.com
ORCID iD: 0000-0003-2617-8707
SPIN-code: 8499-0269
Russian Federation, Ryazan

Igor Yu. Nebyvaev

Ryazan State Medical University

Email: igorpush2012@gmail.com
ORCID iD: 0000-0001-5383-7144
SPIN-code: 3091-4912
Russian Federation, Ryazan

References

  1. Dedov II, Mokrysheva NG, Mel’nichenko GA, et al. Obesity. Consilium Medicum. 2021;23(4):311–325. doi: 10.26442/20751753.2021.4.200832 EDN: GYUVLJ
  2. Yumuk V, Frühbeck G, Oppert JM, et al. An EASO position statement on multidisciplinary obesity management in adults. Obes Facts. 2014;7(2):96–101. doi: 10.1159/000362191 EDN: SOELDT
  3. Mendoza MF, Kachur SM, Lavie CJ. Hypertension in obesity. Curr Opin Cardiol. 2020;35(4):389–396. doi: 10.1097/hco.0000000000000749
  4. Kachur S, Lavie CJ, de Schutter A, et al. Obesity and cardiovascular diseases. Minerva Med. 2017;108(3):212–228. doi: 10.23736/s0026-4806.17.05022-4
  5. Lavie CJ, Pandey A, Lau DH, et al. Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis: Effects of Weight Loss and Exercise. J Am Coll Cardiol. 2017;70(16):2022–2035. doi: 10.1016/j.jacc.2017.09.002
  6. Kotlyarov SN. Place of Lipid Theory in History of Study of Atherosclerosis. I.P. Pavlov Russian Medical Biological Herald. 2024;32(4):681–689. doi: 10.17816/PAVLOVJ636812 EDN: EPMFTH
  7. Lopukhova IV, Korolev AA, Nikitenko EI, et al. A comparative Hygienic Evaluation of Balance of Lipid Components in the Diet of Medical University Students. I.P. Pavlov Russian Medical Biological Herald. 2023;31(2): 203–210. doi: 10.17816/PAVLOVJ111844 EDN: UVTPUB
  8. Alpert MA, Karthikeyan K, Abdullah O, et al. Obesity and Cardiac Remodeling in Adults: Mechanisms and Clinical Implications. Prog Cardiovasc Dis. 2018;61(2):114–123. doi: 10.1016/j.pcad.2018.07.012
  9. Mitrofanova LB, Platonov PG. Morphology of interatrial septum and interatrial connections in the patients with atrial fibrillation. Vestnik Aritmologii. 2002;(30):43–49. EDN: HSQGUR
  10. Suzuki F, Tsuchihashi H, Sano T. New conduction pathways from the left atrium to the right atrium and to the ventricle along the anterior and posterior portions of the left A-V ring. Jpn Heart J. 1974;15(4):385–400. doi: 10.1536/ihj.15.385
  11. Moseychuk KA, Sinyaeva AS, Filippov EV. Fibroid Heart Markers in Patients with Atrial Fibrillation. Doktor.Ru. 2020;19(5):14–18. doi: 10.31550/1727-2378-2020-19-5-14-18 EDN: BMWWJR
  12. Blagova OV, Sulimov VA, Nedostup AV, et al. Myocardial biopsy in general care clinic: patients selection, the results, significance for treatment strategy. Russ J Cardiol. 2015;(5):82–92. EDN: TWQVVZ
  13. Razin VA, Gimaev RH. Myocardial fibrosis in arterial hypertension. Ul'yanovskiy Mediko-biologicheskiy Zhurnal. 2013;(3):7–14. (In Russ.) EDN: RNJLCH
  14. Osipova OA, Golovin AI, Belousova ON, et al. Age-associated level of myocardial fibrosis markers and chemokines in patients with acute coronary syndrome. Cardiovascular Therapy and Prevention. 2021;20(5):2985. doi: 10.15829/1728-8800-2021-2985 EDN: NVJLMQ
  15. Burke AP, Litovsky S, Virmani R. Lipomatous hypertrophy of the atrial septum presenting as a right atrial mass. Am J Surg Pathol. 1996;20(6):678–685. doi: 10.1097/00000478-199606000-00004
  16. Mitrofanova LB, Mikhailov EN, Lebedev DS. Histological and electrophysiological characteristics of the postero superior part of the interatrial septum. Vestnik Aritmologii. 2008;(52):20–26. EDN: RTZYOF
  17. Reyes CV, Jablokow VR. Lipomatous hypertrophy of the cardiac interatrial septum. A report of 38 cases and review of the literature. Am J Clin Pathol. 1979;72(5):785–788. doi: 10.1093/ajcp/72.5.785
  18. Sahin T, Kiliç T, Celikyurt UY, et al. Lipomatous hypertrophy of the interatrial septum: a case report. Turk Kardiyol Dern Ars. 2009;37(3): 187–189.
  19. Tsygankov DA, Polikutina OM. Obesity as a risk factor for cardiovascular disease: focus on ultrasound. Russian Journal of Cardiology. 2021;26(5): 4371. doi: 10.15829/1560-4071-2021-4371 EDN: IJQDMP
  20. Solov’yeva AV, Cherdantseva TM, Cheskidov AV, et al. Clinical and Morphological Features of Lipomatous Hypertrophy of Interatrial Septum in Patients with Diseases of Cardiovascular System. Science of the Young (Eruditio Juvenium). 2022;10(2):157–164. doi: 10.23888/HMJ2022102157-164 EDN: RLFQSW
  21. Uryas’yev OM, Solov’yeva AV, Cheskidov AV, et al. Prognostic Significance of Cardiac Fat Deposits in Patients with Coronary Heart Disease. I.P. Pavlov Russian Medical Biological Herald. 2023;31(2):221–230. doi: 10.17816/PAVLOVJ322796 EDN: WBEUIS

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Histological examination of the interatrial septum: a — overgrowth of connective tissue, hypertrophy of cardiac myocytes; b — increased content of adipose tissue. Staining with hematoxylin and eosin, magnification ×100.

Download (371KB)

Copyright (c) 2025 Eco-Vector


Media Registry Entry of the Federal Service for Supervision of Communications, Information Technology and Mass Communications (Roskomnadzor) PI No. FS77-76803 dated September 24, 2019.